Muscular Dystrophy - Wu Stem Cells Medical Center - A Leading Medical Center for Stem Cell Therapy

eg.stem cell, stem cell treatment

Muscular dystrophy (MD) refers to a group of hereditary muscle diseases that weaken the muscles that move the human body. Muscular dystrophies are characterized by progressive skeletal muscle weakness, defects in muscle proteins, and the death of muscle cells and tissue. Nine diseases including Duchenne, Becker, limb girdle, congenital, facioscapulohumeral, myotonic, oculopharyngeal, distal, and Emery-Dreifuss are always classified as muscular dystrophy.

[News] T��4 Increases Skeletal Muscle And May Treat Duchenne Muscular Dystrophy

[others] Aimene-Muscular dystrophy(Arab)Posted on February 23, 2010

[others] Gnana -Muscular dystrophy(Arab) Posted on 22 February, 2010

[Case Analysis] Stem Cell Therapy for Progressive Muscular Dystrophy (July 20, 2009) Drs. Wu, Wang and Xu

The patient is a 6-year-old male. He was presented with progressive, aggravated and incapacitation of all four limbs for the past 3 years.

[Research & Advances] 'Jekyll and Hyde' Cell May Hold Key to Muscular Dystrophy, Fibrosis Treatme

[Research & Advances] Progress Made Toward Early Identification Of Muscular Dystrophy

[Research & Advances] Muscular Dystrophy: New Drug Promises Benefit Without Risk Of Infection

[Research & Advances] Broad Therapy For Muscular Dystrophy

[Research & Advances] Gene therapy for muscular dystrophy shows promise beyond safety
Researchers have cleared a safety hurdle in efforts to develop a gene therapy for a form of muscular dystrophy that disables patients by gradually weakening muscles near the hips and shoulders.

[Research & Advances] Researchers Trace Effects of Genetic Defect in Myotonic Muscular Dystrophy
Research on the genetic defect that causes myotonic muscular dystrophy has revealed that the mutation disrupts an array of metabolic pathways in muscle cells through its effects on two key proteins. A study published in Nature Structural & Molecular Biology shows that the loss of a single protein accounts for most of the molecular abnormalities associated with the disease, while loss of a second protein also seems to play an important role.

[Research & Advances] Inflammation clue to fragile bones in muscular dystrophy
Inflammation could contribute to bone loss in Duchenne's muscular dystrophy (DMD), a discovery made by a group of Italian researchers. Dr Anna Rufo and her colleagues found that levels of an inflammatory molecule, known as IL-6, are high in patients with DMD.

[Treatment we offer] Muscular dystrophy